Edward Hospital in Naperville, Ill., is offering a fecal microbiota transplant procedure that can help combat recurrent C. difficile infection, according to a Chicago Tribune report.
Here are four key points:
1. The procedure is FDA-approved, but still experimental.
2. However, it has been found to have a 90 percent-plus cure rate and is being increasingly adopted by healthcare providers.
3. In FMT, stool from a healthy donor's system is transplanted into a C. diff patient's colon.
4. The transplant can help reverse the bacterial imbalance that prevents the patient from fighting C. diff.